Service Evaluation to Review Time from ‘decision to treat’ in Treatment Naïve Multiple Sclerosis patients, to Time to Start Treatment at The Walton Centre NHS Foundation Trust
By Sian Lofthouse, neurosciences antimicrobial pharmacist & Ruth Bennett, neurosciences pharmacist, The Walton Centre NHS Foundation Trust
Project poster
Project write up
More Neuropharmacy Academy Service audit Projects
Annual Review and Outcome Measures in Neurology Patients Receiving Immunoglobulin Therapy: A Clinical Audit
By Saeema Murshid, advanced clinical pharmacist, Mid Yorkshire Teaching Trust
From Diagnosis to Treatment: Timeframe Analysis for Initiating Disease-Modifying Therapy (DMT) in Multiple Sclerosis (MS) Patients at University Hospitals Plymouth
By Khadijah Olusekun, Advanced Specialist Pharmacist for Multiple Sclerosis, Parkinson's Disease and Headache, UHP Trust
A Clinical Audit: Prescribing of Valproate in a GP Surgery
By Safoora Azimi, Senior lecturer and senior general practice clinical pharmacist, University of Brighton and Sussex Primary Care
Developing neuropharmacists, supporting collaborative care
Knowledgeable pharmacists can initiate or support new treatment pathways, play an important role in patient education, medicine adherence, efficacy and safety, and provide advice to other healthcare professionals involved in the person's care. This Academy recognises the value of this essential role, and seeks to enhance pharmacist's clinical skills and build their confidence in managing a range of neurological conditions.